206 related articles for article (PubMed ID: 32270418)
21. ASO Author Reflections: Prognostic Role of a Coagulation Index for Patients with Esophageal Squamous Cell Cancer.
Wang Q; Cao B; Mi K
Ann Surg Oncol; 2021 Dec; 28(13):8462-8463. PubMed ID: 34106387
[No Abstract] [Full Text] [Related]
22. ASO Author Reflections: Timing of Oesophagectomy After Neoadjuvant Chemoradiotherapy for Locally Advanced Oesophageal Cancer.
Xiao X; Cheng C; Cheng L; Yuan Y
Ann Surg Oncol; 2023 Feb; 30(2):897-898. PubMed ID: 36322273
[No Abstract] [Full Text] [Related]
23. ASO Author Reflections: Using Efficacy Index to Clarify the Clinical Value of Each Lymph Node Station for Esophageal Squamous Cell Carcinoma.
Nie X; Li K; Peng L; Leng X
Ann Surg Oncol; 2023 Sep; 30(9):5866-5867. PubMed ID: 37322279
[No Abstract] [Full Text] [Related]
24. ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.
Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
Ann Surg Oncol; 2021 Dec; 28(13):8448-8449. PubMed ID: 34143335
[No Abstract] [Full Text] [Related]
25. ASO Author Reflections: A Novel, Sensitive, and Effective Index in Predicting Therapeutic Response of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Ann Surg Oncol; 2024 Jan; 31(1):241-242. PubMed ID: 37838649
[No Abstract] [Full Text] [Related]
26. ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment.
Kataoka A; Yamada K; Kawamura YI
Ann Surg Oncol; 2021 Sep; 28(9):5382-5383. PubMed ID: 33454876
[No Abstract] [Full Text] [Related]
27. ASO Author Reflections: Preservation of the Thoracic Duct is Feasible for Esophageal Squamous Cell Carcinoma Patients Treated with Esophagectomy After Neoadjuvant Chemoradiotherapy.
Oshikiri T; Numasaki H; Oguma J; Toh Y; Watanabe M; Muto M; Kakeji Y; Doki Y
Ann Surg Oncol; 2023 May; 30(5):2699-2700. PubMed ID: 36629993
[No Abstract] [Full Text] [Related]
28. ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Shimomura A; Yamada K; Kawamura YI
Ann Surg Oncol; 2024 Jan; 31(1):243-244. PubMed ID: 37851200
[No Abstract] [Full Text] [Related]
29. Is the outcome of a salvage surgery for T4 thoracic esophageal squamous cell carcinoma really poor?
Akutsu Y; Kono T; Uesato M; Hoshino I; Murakami K; Aoyagi T; Ota T; Toyozumi T; Suito H; Kobayashi H; Harada R; Uno T; Matsubara H
World J Surg; 2014 Nov; 38(11):2891-7. PubMed ID: 24952078
[TBL] [Abstract][Full Text] [Related]
30. ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma.
Okumura H; Noda M; Natsugoe S
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):715-716. PubMed ID: 30288651
[No Abstract] [Full Text] [Related]
31. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.
Kiyozumi Y; Yoshida N; Ishimoto T; Yagi T; Koga Y; Uchihara T; Sawayama H; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Matsuyama T; Oya N; Baba H
World J Surg; 2018 Sep; 42(9):2887-2893. PubMed ID: 29423738
[TBL] [Abstract][Full Text] [Related]
32. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.
Mitchell KG; Nelson DB; Corsini EM; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Sepesi B; Walsh GL; Bhutani MS; Maru DM; Wu CC; Nguyen QN; Ajani JA; Swisher SG; Hofstetter WL
Dis Esophagus; 2020 Mar; 33(3):. PubMed ID: 31313820
[TBL] [Abstract][Full Text] [Related]
33. Minimally invasive hybrid surgery: A salvage tumor enucleation for local recurrence of thoracic esophageal carcinoma after definitive chemoradiotherapy.
Kanamori J; Abe S; Kurita D; Ishiyama K; Hirano Y; Oguma J; Oda I; Saito Y; Daiko H
Asian J Endosc Surg; 2021 Jan; 14(1):77-80. PubMed ID: 32633076
[TBL] [Abstract][Full Text] [Related]
34. Salvage Esophagectomy for Residual Tumor After Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Invading the Neighboring Organs: Is it a Feasible Choice?
Watanabe M
Ann Surg Oncol; 2020 Sep; 27(9):3107-3108. PubMed ID: 32382893
[No Abstract] [Full Text] [Related]
35. ASO Author Reflections: Timing of Surgery and Chemoradiation for Esophageal Squamous Cell Carcinoma.
Wong LY; Berry MF
Ann Surg Oncol; 2023 Apr; 30(4):2224-2225. PubMed ID: 36607525
[No Abstract] [Full Text] [Related]
36. ASO Author Reflections: Intramural Metastasis as Dismal Prognostic Factor in Esophageal Squamous Cell Carcinoma.
Ushimaru Y; Makino T; Doki Y
Ann Surg Oncol; 2023 Aug; 30(8):5203-5204. PubMed ID: 37285094
[No Abstract] [Full Text] [Related]
37. ASO Author Reflections: A Novel Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma.
Yuan Y; Hong HG; Chen LQ
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):782-783. PubMed ID: 31605350
[No Abstract] [Full Text] [Related]
38. ASO Author Reflections: Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma.
Kumakura Y; Yokobori T; Sohda M; Shirabe K; Kuwano H
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):741-742. PubMed ID: 30315381
[No Abstract] [Full Text] [Related]
39. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
Tachimori Y; Kanamori N; Uemura N; Hokamura N; Igaki H; Kato H
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):49-54. PubMed ID: 19154902
[TBL] [Abstract][Full Text] [Related]
40. ASO Author Reflections: Implementation of Age and Co-morbidity in the Treatment Guideline of Patients with Esophageal Squamous Cell Carcinoma.
Faiz Z; Plukker JTM
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):585-586. PubMed ID: 31011909
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
